NEW YORK (GenomeWeb News) – Waters today reported an 8 percent spike year over year in its fourth quarter revenues as the firm beat the average Wall Street analyst estimates on the top and bottom lines.

For the three months ended Dec. 31, 2013, Waters' total revenues increased to $565.4 million from $521.8 million in the prior-year period, besting the consensus analyst estimate of $535.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.